{
  "docId": "019de071-41d7-735b-bdce-76898f0847d2",
  "docSlug": "eaafde7daeccaea38d88b7264ade91c5",
  "documentTitle": "Erasca | IPO Presentation Deck | 46 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 32,
  "pageCount": 46,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 20,
  "notes": "The slide presents technical pharmacological data to support the drug's viability.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-41d7-735b-bdce-76898f0847d2/32",
  "deckHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2",
  "deckJsonHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2.json",
  "deckAnchorHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.48,
        "y": 0.53
      },
      "kind": "list",
      "text": "Low DDI risk and no CYP flags make ERAS-601 well suited for combination therapy. Low in vivo Cl and high bioavailability in multiple species suggest favorable human PK profile.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccb051ff-6934-4809-8d97-31e3efeab854",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.45,
        "x": 0.02,
        "y": 0.22
      },
      "kind": "table",
      "text": "Assay and ERAS-601 values for physicochemical and ADME properties.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1dd19210-7af2-4613-a01c-0ca207f24061",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.48,
        "y": 0.22
      },
      "kind": "table",
      "text": "PK parameters for ERAS-601 across Mouse, Rat, and Dog.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "705b1df7-fe64-437b-b3a5-d4f39a5ef6c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.96,
        "x": 0.02,
        "y": 0.05
      },
      "kind": "title",
      "text": "ERAS-601 demonstrated favorable physicochemical, ADME, and PK properties, which support its development as a combination therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60961be6-a1dc-421e-97cb-f42058c3c80f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "77880850-840a-466d-a274-fae5661b57ba",
      "evidence": "table/data: Assay and ERAS-601 values for physicochemical and ADME properties.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}